Evidence map›Paper›PMID 12958218›Full record

ReviewJournal of clinical microbiology2003

Laboratory aspects of management of chronic pulmonary infections in patients with cystic fibrosis.

Melissa B Miller, Peter H Gilligan

Abstract readReview
In one paragraph

Review in Journal of clinical microbiology, 2003. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Phenotypic characteristics of incident and chronic MRSA isolates in cystic fibrosis.Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society · 2021
    Article
  5. Clinical microbiology reviews · 2020
    Review
  6. Observational
  7. Observational
  8. Article
  9. Article
  10. Article
  11. Article
  12. Evaluation of colistin susceptibility in multidrug-resistant clinical isolates from cystic fibrosis, France.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2013
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Melissa B MillerClinical Microbiology-Immunology Laboratories, University of North Carolina Hospitals, University of North Carolina School of Medicine Chapel Hill, North Carolina 27514, USA.
Peter H Gilligan

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Bacterial InfectionsBurkholderia InfectionsChronic DiseaseCystic FibrosisHumansLung DiseasesPseudomonas InfectionsStaphylococcal Infections

Identifiers

PMID12958218
PMCPMC193835

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.